167 related articles for article (PubMed ID: 26261610)
1. Expression of poly(C)-binding protein 1 (PCBP1) in NSCLC as a negative regulator of EMT and its clinical value.
Liu Y; Gai L; Liu J; Cui Y; Zhang Y; Feng J
Int J Clin Exp Pathol; 2015; 8(6):7165-72. PubMed ID: 26261610
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1.
Li J; Feng Q; Wei X; Yu Y
Tumour Biol; 2016 Nov; 37(11):15221-15228. PubMed ID: 27683057
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
[TBL] [Abstract][Full Text] [Related]
4. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.
Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH
Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929
[TBL] [Abstract][Full Text] [Related]
5. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q
Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
[TBL] [Abstract][Full Text] [Related]
7. Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype.
Zhang L; Zhang J; Ma Y; Chen J; Dong B; Zhao W; Wang X; Zheng Q; Fang F; Yang Y
Lung Cancer; 2015 Sep; 89(3):320-8. PubMed ID: 26144287
[TBL] [Abstract][Full Text] [Related]
8. Low expression of the FoxO4 gene may contribute to the phenomenon of EMT in non-small cell lung cancer.
Xu MM; Mao GX; Liu J; Li JC; Huang H; Liu YF; Liu JH
Asian Pac J Cancer Prev; 2014; 15(9):4013-8. PubMed ID: 24935588
[TBL] [Abstract][Full Text] [Related]
9. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W
Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741
[TBL] [Abstract][Full Text] [Related]
10. The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer.
Al-Saad S; Al-Shibli K; Donnem T; Persson M; Bremnes RM; Busund LT
Br J Cancer; 2008 Nov; 99(9):1476-83. PubMed ID: 18854838
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of epithelial-mesenchymal transition-related markers between cancer tissue and tumor emboli].
He N; Wu GF; Zhao HY; Han HX
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):758-61. PubMed ID: 22336160
[TBL] [Abstract][Full Text] [Related]
12. Downregulated vimentin and upregulated E-cadherin in T1 stage non-small-cell lung cancer: does it suggest a mesenchymal-epithelial transition?
Luo T; Wang L; Wu P; Gong W; Chen W; Zhao H; Zheng Z
Neoplasma; 2017; 64(5):693-699. PubMed ID: 28592120
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-mesenchymal Transition (EMT) is Correlated with Patient's Prognosis of Lung Squamous Cell Carcinoma.
Aruga N; Kijima H; Masuda R; Onozawa H; Yoshizawa T; Tanaka M; Inokuchi S; Iwazaki M
Tokai J Exp Clin Med; 2018 Apr; 43(1):5-13. PubMed ID: 29637533
[TBL] [Abstract][Full Text] [Related]
14. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin expression in surgically-resected non-small cell lung cancers--a clinicopathological study.
Lee YC; Wu CT; Chen CS; Chang YL
Thorac Cardiovasc Surg; 2000 Oct; 48(5):294-9. PubMed ID: 11100763
[TBL] [Abstract][Full Text] [Related]
16. α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma.
Ding L; Zhang Z; Shang D; Cheng J; Yuan H; Wu Y; Song X; Jiang H
J Oral Pathol Med; 2014 May; 43(5):335-43. PubMed ID: 24313357
[TBL] [Abstract][Full Text] [Related]
17. A switch from epithelial to mesenchymal properties correlates with lymphovascular invasion in squamous cell carcinoma of the penis.
May M; Brookman-May S; Burger M; Koch S; Otto W; Bründl J; Albrecht K; Denzinger S
Pathol Res Pract; 2015 Sep; 211(9):641-5. PubMed ID: 26092595
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-to-mesenchymal transition in human esophageal cancer associates with tumor progression and patient's survival.
Liu J; Chen L; Deng H; Xu B; Li M; Zheng X; Wu C; Jiang J
Int J Clin Exp Pathol; 2014; 7(10):6943-9. PubMed ID: 25400779
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites.
Mitselou A; Batistatou A; Nakanishi Y; Hirohashi S; Vougiouklakis T; Charalabopoulos K
Histol Histopathol; 2010 Oct; 25(10):1257-67. PubMed ID: 20712010
[TBL] [Abstract][Full Text] [Related]
20. Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.
Costa LC; Leite CF; Cardoso SV; Loyola AM; Faria PR; Souza PE; Horta MC
J Appl Oral Sci; 2015; 23(2):169-78. PubMed ID: 26018309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
